Ehud Geller - 18 Mar 2026 Form 3 Insider Report for REGENTIS BIOMATERIALS LTD. (RGNT)

Role: Chief Executive Officer, Director
Signature: /s/ Ehud Geller
Issuer symbol: RGNT
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 16:30:11 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
GELLER EHUD	Chief Executive Officer, Director	C/O REGENTIS BIOMATERIALS LTD., 60 MEDINAT HAYEHUDIM, HERZLIYA, ISRAEL	/s/ Ehud Geller	18 Mar 2026	0001284386

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RGNT	Employee Stock Option (Right to Buy)							18 Mar 2026	Common Stock	182,000	$0.0100	Direct	F1
holding	RGNT	Employee Stock Option (Right to Buy)							18 Mar 2026	Common Stock	283,533	$0.0100	Direct	F2
holding	RGNT	Warrants to purchase ordinary shares							18 Mar 2026	Common Stock	92,821	$5.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option grant is fully vested as of this date.
F2	This option grant is fully vested as of this date.
F3	The warrants are currently exercisable and have a three year term.